Drug Eluting Stent - India CDSCO Medical Device Registration

Drug Eluting Stent is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/MD/2023/000475_d54e4aab53783a99ea3989a3d6573296_9b60375db7fc89d88c8dcdeed73ab706. This device is marketed under the brand name Sirolimus. The license holder is Newtech Medical Devices Pvt. Ltd., and it is classified as Device Class Class D. The approving authority is Sub Zonal Baddi.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

CDSCO Registered

Class Class D

Drug Eluting Stent

UID: MFG/MD/2023/000475_d54e4aab53783a99ea3989a3d6573296_9b60375db7fc89d88c8dcdeed73ab706

Brand Name

Sirolimus

License Holder

Newtech Medical Devices Pvt. Ltd.

Device Class

Class D

Approving Authority

Sub Zonal Baddi

Product Information

Everolimus Coronary Stent System is indicated for improving coronary lumia diameters in patients including those with diabetes, mellitus with symptomatic ischemic heart disease Stable angina Unstable angina non-ST elevation documented due to arthersclerotic lesions in native coronary arteries.